Home / Companies / Aparna Pharmaceuticals Private Limited

Aparna Pharmaceuticals Private Limited

FDA Regulatory Profile

Aparna Pharmaceuticals Private Limited has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record.

Latest inspection
Sep 12, 2023 · VAI

Reviewing Aparna Pharmaceuticals Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Aparna Pharmaceuticals Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections2Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Recent FDA Inspections

DateSiteProductClassificationFEI
Sep 12, 2023Pyidibhimavaram, Srikakulam, IndiaDrugsVoluntary Action Indicated (VAI)3012390454
Mar 15, 2019Pyidibhimavaram, Srikakulam, IndiaDrugsOfficial Action Indicated (OAI)3012390454

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3012390454Pyidibhimavaram, Srikakulam, India2Sep 12, 2023

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.